Ignite Creation Date:
2024-05-06 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05157542
Status:
UNKNOWN
Last Update Posted:
2021-12-15
First Post:
2021-05-24
Brief Title:
Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
Sponsor:
Juan LI MD
Organization:
Sichuan Cancer Hospital and Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-24
First Submit QC Date:
December 2 2021
Study First Post Date:
2021-12-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-02
Last Update Post Date:
2021-12-15
Last Update Post Date Type:
ACTUAL